Quality Assurance Engineer - Process and Validation (930)

About Civica: Over the past two decades, shortages of generic, injectable medications critical to the lifesaving work of hospitals in the United States have become commonplace and have reached an all time high. Over 300 essential medications are reported to be in shortage, according to industry and FDA reports. “Race to the bottom” pricing of mostly sterile injectable medications, manufacturing challenges and predatory pricing are both the causes and results. Who suffers most? Patients. Civica is a 501(c)(4) social welfare organization established in 2018 by health systems (CommonSpirit Health, HCA Healthcare, Intermountain Healthcare, Mayo Clinic, Providence St. Joseph Health, SSM Health, and Trinity Health) and philanthropies (Gary and Mary West Foundation, Laura and John Arnold Foundation, and Peterson Center on Healthcare) to reduce chronic generic drug shortages and related high prices in the United States. An experienced team of health care and pharmaceutical industry leaders leads the organization. Today, more than 55 health systems have joined Civica. They represent over 1,500 hospitals and over 30 percent of all U.S. hospital beds. Civica has also supplied the U.S. Department of Veteran’s Affairs, the U.S. Department of Defense, and the U.S. Strategic National Stockpile of essential medicines. Since established, the 1 Policy for the Civica team has been “Do What Is in the Best Interest of Patients.” Civica has expanded its mission beyond the hospital setting to include lowering the cost of medications at the pharmacy counter. It has launched a sister organization, CivicaScript, to enter the retail pharmacy market partnering with Blue Cross Blue Shield entities and others with the goal of reducing select high cost generic drugs where market forces are not working to control drug costs. More recently, Civica announced plans to develop, manufacture and deliver affordable biosimilar insulin, The consistent availability of affordable insulin will benefit people who ration their care or who have been forced to choose between this life-sustaining medicine and living expenses. Those who are uninsured or underinsured often pay the most out of pocket for their medications. Long- and short-acting insulins will be produced and available in both vials and pre-filled pens – at no more than $30 per vial and no more than $55 for a pack of five pens. Learn more about Civica’s plans and progress at www.civicarx.org Job Description Responsibilities of the position include supporting quality systems and oversight to ensure the product process validation, cleaning validation, Quality Risk Management and quality laboratory systems meet cGMP and Civica compliance requirements at the onset of building the facility leading to successful U.S. Food and Drug Administration (FDA) approval of the facility and the ongoing introduction and approval of new medications. Responsibilities also include, but are not limited to, the generation, review and/or approval of policies, procedures, reports, and other records necessary to provide quality oversight to ensure FDA requirements are met. Essential Duties and Responsibilities: Work with validation and engineering teams to provide Quality oversight for validation and qualification activities and ensure work is performed in a compliant and controlled manner. Participate in Quality Risk Management and analysis. Maintain current knowledge of local and international regulatory and legislative requirements and trends to ensure that expert advice and appropriate technical support on all quality related matters is provided to the site. Support product process transfers, including validation, from and/or to other manufacturing sites. Support activities related to product introduction to the site. Support aseptic process simulations. Support quality processes and systems across the product lifecycle including, but not limited to, change control, CAPA, deviations and investigations, laboratory control, Annual Product Quality Review (APQR), and management notification. Provide quality review and support for laboratory method validation/verification and laboratory information management system (LIMS). Provide support to equipment, facilities and utilities qualification as needed. Work collaboratively to resolve problems by taking risk-based and compliant approaches to solutions. Promote a quality mindset and quality excellence approach to all activities. Promote a safety mindset and focus on safety for all operations activities. Travel (up to 5%) may be required Basic Qualifications and Capabilities: Bachelor’s degree in a scientific discipline with 4 years Quality/cGMP experience in the pharmaceutical industry. Experience in process and cleaning validation, LIMS systems, Aseptic Process Simulations and Quality Risk Management. Knowledge in 21CFR Part 11, Electronic Records and Signatures and data integrity is required. Participation and leading activities to support regulatory agency inspections required. Project management, organization, and execution skills are required. Ability to apply technical expertise to solve problems and issues. Participating in and leading activities that support regulatory agency inspections is required. Excellent interpersonal and written communication skills and experience using various software/electronic applications required. Self-motivated, flexible, and able to work in a small, fast-paced, dynamic, environment. Ability to work autonomously and within established guidelines, procedures, and practices. Committed to delivering high quality results, working with others to overcome challenges, and focusing on what matters. Committed to delivering high-quality results, working with others to overcome challenges, and focusing on what matters. Continuously looking for opportunities to learn, build skills, and share knowledge with others. Preferred Qualifications: Technical expertise in sterile pharmaceutical isolator technology, combination product and medical devices.